543828 — Sudarshan Pharma Industries Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹8.07bn
- IN₹10.83bn
- IN₹7.03bn
Annual cashflow statement for Sudarshan Pharma Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 71.9 | 95 | 152 | 216 | 305 |
| Depreciation | |||||
| Non-Cash Items | 32.1 | 49.1 | 81.6 | 178 | 207 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -150 | -441 | -186 | -64.2 | -573 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -37.4 | -288 | 60.1 | 352 | -23 |
| Capital Expenditures | -16.6 | -138 | -37.8 | -47.5 | -691 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.69 | -118 | -17.1 | -157 | -86 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -14.9 | -257 | -54.9 | -204 | -777 |
| Financing Cash Flow Items | -34.8 | -54 | -89.4 | -117 | -247 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 42.1 | 659 | -121 | -144 | 792 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.2 | 115 | -116 | 3.69 | -8.26 |